Mechanisms for rescue of correctable folding defects in CFTRDelta F508

Diane E Grove1, Meredith F N Rosser, Hong Yu Ren

  • 1Department of Cell and Developmental Biology and the UNC-Cystic Fibrosis Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Insights

Inactivating RMA1 or CHIP ubiquitin ligases helps cystic fibrosis (CF) transmembrane conductance regulator (CFTR)DeltaF508 folding. Combining these with correctors enhances CFTR folding, offering a potential therapeutic strategy for CF.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • Cystic Fibrosis (CF) is caused by premature degradation of the CFTRDeltaF508 protein.
  • Folding correctors are investigated as therapeutics, but the cellular environment's impact on CFTRDeltaF508 folding efficiency remains unclear.

Purpose of the Study:

  • To investigate how cellular environment modulation affects CFTRDeltaF508 folding.
  • To identify correctable folding defects in CFTRDeltaF508.

Main Methods:

  • Inactivation of RMA1 or CHIP ubiquitin ligases.
  • Treatment with the folding corrector Corr-4a.
  • Analysis of CFTRDeltaF508 folding efficiency and localization.

Main Results:

  • RMA1 or CHIP inactivation allowed CFTRDeltaF508 to escape endoplasmic reticulum retention.
  • Combined inactivation and Corr-4a treatment enhanced CFTRDeltaF508 folding 3-7 fold compared to Corr-4a alone.
  • RMA1 and CHIP recognize different CFTR regions, with RMA1 acting on nascent CFTRDeltaF508.

Conclusions:

  • Modulating ER quality control by inactivating RMA1/CHIP can significantly improve CFTRDeltaF508 folding.
  • Some, but not all, folding defects are correctable, suggesting targeted therapeutic approaches.
  • This strategy holds potential for developing new CF therapies.

Related Concept Videos

Protein Folding Quality Check in the RER01:29

Protein Folding Quality Check in the RER

ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...